Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record.

The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia

Stoner, Elizabeth, The Finasteride Study Group Participating clinics and investigators:S002253471737547X-bccd8dc81dd3b0b3e56165b279cc80b2 R.B. Bracken, S002253471737547X-5599b4d1f4191bbcc4f4a104315e31df E. Stein and S002253471737547X-e4a7c56d4dc68f35368de96a0629b4c0 K. Franke University of Cincinnati Medical Center, Cincinnati, Ohio S002253471737547X-1d7899fed0308a6eaa632fe3fbd85044 J. Geller and S002253471737547X-e14c1d3cf5170c47ba0d84e670ee2e41 C. Pratt Mercy Hospital and Medical Center, and Harborview Hospital, San Diego, · 1992 · Journal of Urology

Abstract

Finasteride (Proscar--an orally active 5 alpha-reductase enzyme inhibitor) blocks the conversion of testosterone to dihydrotestosterone. The effects of finasteride in patients with benign prostatic hyperplasia were investigated in 2 double-blind, placebo-controlled studies. In study 1, 86 patients were treated with placebo or finasteride (5 to 80 mg. per day) for 12 weeks, followed by a 12-week drug-free period. After 12 weeks of treatment all doses of finasteride showed significant decreases in prostate volume. However, 12 weeks after discontinuation of finasteride prostate volume returned to near baseline values. In study 2, 104 patients were treated with placebo or finasteride (0.2 to 40 mg. per day) for 24 weeks. After 24 weeks of finasteride treatment prostate volume showed a mean decrease of 24% and 28% (p less than 0.01) in the 1 and 5 mg. groups, respectively. Lower doses had a lesser effect on prostate shrinkage. Maximum urinary flow showed a mean increase of 3.7 cc per second when the 1 and 5 mg. groups were combined. Symptom improvement was observed in the 1 and 5 mg. groups, although this was not statistically different from the placebo group due to the small sample size.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-5347(17)37547-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Stoner, E., & The Finasteride Study Group Participating clinics and investigators:S002253471737547X-bccd8dc81dd3b0b3e56165b279cc80b2 R.B. Bracken, S.-5. E. S. A. S.-E. K. F. U. O. C. M. C.
Venue
Journal of Urology
Published
1992-05
Volume
147
Issue
5
Pages
1298-1302
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W2404555905
Cited by
166
References
0
FWCI
29.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia. https://app.cochat.ai/papers/10.1016/s0022-5347(17)37547-x
The paper
Stoner, E., & The Finasteride Study Group Participating clinics and investigators:S002253471737547X-bccd8dc81dd3b0b3e56165b279cc80b2 R.B. Bracken, S.-5. E. S. A. S.-E. K. F. U. O. C. M. C. (1992). The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic Hyperplasia. Journal of Urology. https://doi.org/10.1016/s0022-5347(17)37547-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.